Comparative Effects of Focused and Radial Shock-Wave Therapies in Hip Osteoarthritis.

Hip Osteoarthritis Clinical Trial

Official title:

Comparative Effects of Focused (Large Focused) and Radial (Controlled Unfocused) Shock-Wave Therapies in Hip Osteoarthritis.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05224674
• Other study ID #: Van Yuzuncu Yil University
• Status: Completed
• Phase: N/A
• Start date: January 1, 2022
• Est. completion date: September 30, 2022

Study information

• Verified date: November 2022
• Source: Yuzuncu Yil University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

There is no scientific study in the literature regarding the use of shock wave therapy in hip osteoarthritis. In this study, we aim to investigate both the effectiveness of ESWT and which type of ESWT can be more effective in hip osteoarthritis.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 150
• Est. completion date: September 30, 2022
• Est. primary completion date: August 29, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 50 Years and older

Eligibility

Inclusion Criteria:

• unilateral or bilateral hip osteoarthritis

Exclusion Criteria:

• other disorders that are contraindications for shockwave therapy, not have received ESWT treatment before

Related Conditions & MeSH terms

• Hip Osteoarthritis
• Osteoarthritis
• Osteoarthritis, Hip

Intervention

Device:
• Extracorporeal Shock Wave Therapy (ESWT)
The ESWT device is product of Elettronica Pagani, Italy.

Locations

Country	Name	City	State
Turkey	Volkan Sah	Van

Sponsors (1)

Lead Sponsor	Collaborator
Yuzuncu Yil University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Visual Analogue Scale (VAS)	patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse outcome.	at baseline.
Primary	Visual Analogue Scale (VAS)	patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse outcome	4 weeks after baseline.
Primary	Visual Analogue Scale (VAS)	patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse outcome.	8 weeks after baseline.
Secondary	Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)	24-item questionnaire for osteoarthritis, in the range of 0 to 96, higher scores mean a worse outcome	at baseline.
Secondary	Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)	24-item questionnaire for osteoarthritis, in the range of 0 to 96, higher scores mean a worse outcome	4 weeks after baseline.
Secondary	Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)	24-item questionnaire for osteoarthritis, in the range of 0 to 96, higher scores mean a worse outcome	8 weeks after baseline.